[Gefitinib therapy in non-small-cell lung cancer]

MeSH terms

• Biomarkers, Tumor / analysis
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / mortality
• Carcinoma, Non-Small-Cell Lung / pathology
• ErbB Receptors / antagonists & inhibitors*
• Female
• Finland
• Gefitinib
• Humans
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / mortality
• Lung Neoplasms / pathology
• Male
• Prognosis
• Quinazolines / administration & dosage*
• Risk Assessment
• Survival Analysis
• Treatment Outcome